METHOD FOR TREATMENT AND PREVENTION OF RESPIRATORY INSUFFICIENCY

摘要

The invention relates to the use of a composition comprising eicosapentaenoic acid (EPA, n-3), docosahexaenoic acid (DHA, n-3) and stearidonic acid (STA) and having a weight ratio STA/DHA of at least 0.1 for the manufacture of a pharmaceutical or nutritional composition for the treatment and/or prevention of dust mite induced respiratory insufficiency and/or dust mite allergy.